Effect of the 2010 task force criteria on reclassification of cardiovascular magnetic resonance criteria for arrhythmogenic right ventricular cardiomyopathy

J Cardiovasc Magn Reson. 2014 Jul 4;16(1):47. doi: 10.1186/1532-429X-16-47.

Abstract

Background: We sought to evaluate the effect of application of the revised 2010 Task Force Criteria (TFC) on the prevalence of major and minor Cardiovascular Magnetic Resonance (CMR) criteria for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) versus application of the original 1994 TFC. We also assessed the utility of MRI to identify alternative diagnoses for patients referred for ARVC evaluation.

Methods: 968 consecutive patients referred to our institution for CMR with clinical suspicion of ARVC from 1995 to 2010, were evaluated for the presence of major and minor CMR criteria per the 1994 and 2010 ARVC TFC. CMR criteria included right ventricle (RV) dilatation, reduced RV ejection fraction, RV aneurysm, or regional RV wall motion abnormalities. When quantitative measures of RV size and function were not available, and in whom abnormal size or function was reported, a repeat quantitative analysis by 2 qualified CMR physicians in consensus.

Results: Of 968 patients, 220 (22.7%) fulfilled either a major or a minor 1994 TFC, and 25 (2.6%) fulfilled any of the 2010 TFC criterion. Among patients meeting any 1994 criteria, only 25 (11.4%) met at least one 2010 criterion. All patients who fulfilled a 2010 criteria also satisfied at least one 1994 criterion. Per the 2010 TFC, 21 (2.2%) patients met major criteria and 4 (0.4%) patients fulfilled at least one minor criterion. Eight patients meeting 1994 minor criteria were reclassified as satisfying 2010 major criteria, while 4 patients fulfilling 1994 major criteria were reclassified to only minor or no criteria under the 2010 TFC.Eighty-nine (9.2%) patients had alternative cardiac diagnoses, including 43 (4.4%) with clinically significant potential ARVC mimics. These included cardiac sarcoidosis, RV volume overload conditions, and other cardiomyopathies.

Conclusions: Application of the 2010 TFC resulted in reduction of total patients meeting any diagnostic CMR criteria for ARVC from 22.7% to 2.6% versus the 1994 TFC. CMR identified alternative cardiac diagnoses in 9.2% of patients, and 4.4% of the diagnoses were potential mimics of ARVC.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Arrhythmogenic Right Ventricular Dysplasia / classification
  • Arrhythmogenic Right Ventricular Dysplasia / diagnosis*
  • Arrhythmogenic Right Ventricular Dysplasia / epidemiology
  • Arrhythmogenic Right Ventricular Dysplasia / pathology
  • Arrhythmogenic Right Ventricular Dysplasia / physiopathology
  • Contrast Media
  • Diagnosis, Differential
  • Female
  • Guideline Adherence
  • Heart Ventricles / pathology*
  • Heart Ventricles / physiopathology
  • Humans
  • Hypertrophy, Right Ventricular / diagnosis
  • Hypertrophy, Right Ventricular / epidemiology
  • Hypertrophy, Right Ventricular / pathology
  • Magnetic Resonance Imaging / standards*
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Myocardium / pathology*
  • Practice Guidelines as Topic
  • Predictive Value of Tests
  • Prevalence
  • Retrospective Studies
  • Stroke Volume
  • Ventricular Dysfunction, Right / diagnosis
  • Ventricular Dysfunction, Right / epidemiology
  • Ventricular Dysfunction, Right / pathology
  • Ventricular Function, Right

Substances

  • Contrast Media